Glooko Blog

Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch

October 18, 2021 The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders.” Read more here.

Glooko’s Remote Patient Monitoring for People with Diabetes

August 31, 2021 In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Russ Johannesson, CEO of Glooko. He speaks about the advantages remote monitoring offers to both physicians of diabetics as well as the patients themselves. Read more here.

Russ Johannesson on Setting the Pace in Digital Health

April 30, 2021 To make sure its upcoming connected insulin pen system will work with the user’s choice of daily diabetes management platforms, Eli Lilly & Co. has signed compatibility agreements with four international providers. That includes glucose monitoring sensors, digital health programs and other tools from Roche, Dexcom, Glooko and myDiabby Healthcare. Read more… Continue reading Russ Johannesson on Setting the Pace in Digital Health